(Q40530142)

21 September 2017

title

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants (English)

1 reference

21 September 2017

1 reference

1 reference

1 reference

1 reference

Vesikari T

1

1 reference

21 September 2017

Karvonen A

2

1 reference

21 September 2017

Korhonen T

3

1 reference

21 September 2017

Espo M

4

1 reference

21 September 2017

Lebacq E

5

1 reference

21 September 2017

Forster J

6

1 reference

21 September 2017

Zepp F

7

1 reference

21 September 2017

Delem A

8

1 reference

21 September 2017

De Vos B

9

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

22

1 reference

21 September 2017

issue

21-22

1 reference

21 September 2017

page(s)

2836-2842

1 reference

The estimation of mortality due to rotavirus infections in sub-Saharan Africa

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Rotavirus vaccines against diarrhoeal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Review of rotavirus vaccine trials in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Protection from Rotavirus Reinfection: 2-Year Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Rotavirus infection in infants as protection against subsequent infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus-based reassortant vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Serum transaminase elevations in infants with rotavirus gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Serum aspartate aminotransferase levels after rotavirus gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Mechanisms of protection against rotavirus in humans and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Serum antibody as a marker of protection against natural rotavirus infection and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

The role of serum antibodies in the protection against rotavirus disease: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Population-based study of rotavirus vaccination and intussusception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Intussusception among infants given an oral rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Human rotavirus infection in infants and young children with intussusception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Rotavirus infection and intussusception: a view from retrospect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Lack of an apparent association between intussusception and wild or vaccine rotavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

Cost-effectiveness analysis of a rotavirus immunization program for the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.044

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.01.044

1 reference

21 September 2017

1 reference